Hospital Clonal Outbreak of Fluconazole-Resistant Candida parapsilosis Harboring the Y132F ERG11p Substitution in a French Intensive Care Unit

Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0113022. doi: 10.1128/aac.01130-22. Epub 2023 Feb 28.

Abstract

We report the first identification of a fluconazole-resistant Candida parapsilosis (FR-Cp) strain in our hospital, which subsequently caused an outbreak involving 17 patients (12 deaths) within a 26-bed French intensive care unit. Microsatellite genotyping confirmed that all FR-Cp isolates belonged to the same clone. Given recent reports of rapid dissemination of these emerging clones, routine testing of azole susceptibility for all Candida parapsilosis isolates should be encouraged, at least in ICU patients.

Keywords: Candida parapsilosis; fluconazole resistance; infection prevention and control; intensive care unit; outbreak.

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Candida parapsilosis* / genetics
  • Disease Outbreaks
  • Drug Resistance, Fungal / genetics
  • Fluconazole* / pharmacology
  • Fluconazole* / therapeutic use
  • Hospitals
  • Humans
  • Intensive Care Units
  • Microbial Sensitivity Tests

Substances

  • Fluconazole
  • Antifungal Agents